Search Within

Kelly Fitzgerald

Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
  3. Review (2)
  4. Correspondence (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (14)
  2. GME, Medicine (14)
  3. Graduate Medical Education (14)
  4. Solid Tumor Oncology Division (13)
  5. Genitourinary Oncology Service (12)
  6. Hematologic Malignancies, Division of (11)

More Groups

People
  1. Chung-Han Lee (12)
  2. Robert Motzer (11)
  3. Maria Carlo (10)
  4. Ritesh Kotecha (10)
  5. Andrea Knezevic (9)
  6. Darren Feldman (9)

More People

Years
  1. 2024 (3)
  2. 2023 (6)
  3. 2022 (5)
Publications
  1. Journal of Clinical Oncology (5)
  2. European Urology (2)
  3. Cancer (1)
  4. Cancer Research (1)
  5. European Urology Focus (1)
  6. Journal of the National Comprehensive Cancer Network (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. Elsevier Science, Inc. (2)
  3. American Association for Cancer Research (1)
  4. Elsevier B.V. (1)
  5. Elsevier Inc. (1)
  6. Harborside Press (1)

More Publishers

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cabozantinib plus nivolumab in patients with non–clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Journal Article

    Fitzgerald, K. N.; Lee, C. H.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y.; Lefkowitz, R. A.; Shah, N. J.; Owens, C. N.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Genomic ancestry in kidney cancer: Correlations with clinical and molecular features
    Journal Article

    Kotecha, R. R.; Knezevic, A.; Arora, K.; Bandlamudi, C.; Kuo, F.; Carlo, M. I.; Fitzgerald, K. N.; Feldman, D. R.; Shah, N. J.; Reznik, E.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation
    Journal Article

    Thor, M.; Fitzgerald, K.; Apte, A.; Hun Oh, J.; Iyer, A.; Odiase, O.; Nadeem, S.; Yorke, E. D.; Chaft, J.; Wu, A. J.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes in NF2-mutated RCC treated with contemporary immunotherapy regimens
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Jacobi, R.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Fitzgerald, K. N.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y. B.; Zucker, M.; Lefkowitz, R. A.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic determinants of progression-free survival after second line of therapy (PFS-2) for patients on immunotherapy-based combination therapies for advanced clear cell renal cell carcinoma
    Meeting Abstract

    Fitzgerald, K. N.; Kotecha, R. R.; Knezevic, A.; Shapnik, N.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant therapy options in renal cell carcinoma — Targeting the metastatic cascade
    Review

    Fitzgerald, K. N.; Motzer, R. J.; Lee, C. H.
    Nature Reviews Urology (2023)

    Fulltext@MSK | Save
  • Progression-free survival after second line of therapy for metastatic clear cell renal cell carcinoma in patients treated with first-line immunotherapy combinations
    Research Letter

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Impact of sarcomatoid features on treatment outcomes in metastatic clear cell renal cell carcinoma treated with first-line immunotherapy combinations
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Personalizing first-line management of metastatic renal cell carcinoma: Leveraging current and novel therapeutic options
    Review

    Fitzgerald, K. N.; Lee, C. H.
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save